These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34652116)

  • 1. Schizophrenia: Use of Antipsychotic Drugs for Maintenance Therapy.
    Salisbury-Afshar E
    Am Fam Physician; 2021 Oct; 104(4):355-356. PubMed ID: 34652116
    [No Abstract]   [Full Text] [Related]  

  • 2. Maintenance treatment with antipsychotic drugs for schizophrenia.
    Ceraso A; Lin JJ; Schneider-Thoma J; Siafis S; Tardy M; Komossa K; Heres S; Kissling W; Davis JM; Leucht S
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD008016. PubMed ID: 32840872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maintenance treatment with antipsychotic drugs for schizophrenia.
    Leucht S; Tardy M; Komossa K; Heres S; Kissling W; Davis JM
    Cochrane Database Syst Rev; 2012 May; (5):CD008016. PubMed ID: 22592725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maintenance phase treatment of psychotic disorders in outpatients from Serbia - focus on long-term benzodiazepine use.
    Marić NP; Andrić Petrović S; Jerotić S; Ristić I; Savić B; Zebić M; Vuković V; Britvić D; Golubović O; Jakšić M; Jevđić K; Kolašinac Z; Lalović N; Mirković Ilić J; Nikolić S; Paunović Č; Pavlović Z; Pejović Nikolić S; Perović V; Popović J; Ranđić Avakumović V; Stojanović S; Tatarević M; Živković I; Voskresenski T; Jovanović N
    Int J Psychiatry Clin Pract; 2020 Sep; 24(3):315-321. PubMed ID: 32459564
    [No Abstract]   [Full Text] [Related]  

  • 5. Physicians' and patients' involvement in relapse prevention with antipsychotics in schizophrenia.
    Hamann J; Mischo C; Langer B; Leucht S; Kissling W
    Psychiatr Serv; 2005 Nov; 56(11):1448-50. PubMed ID: 16282267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antipsychotic drugs and relapse prevention.
    Marder SR
    Schizophr Res; 1999 Mar; 35 Suppl():S87-92. PubMed ID: 10190229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of antipsychotic drugs on life quality of schizophrenic patients: one year follow-up study].
    Fang M; Li L; Zhao J; Chen H; Ye M; Guo X; Lu Z; Sun X; Wang C; Xie S; Hu B; Guo T; Ma C; Wang B; Lü L; Liu N; Deng H; Chen Q; Shang X; Gong F; Zhang X; He X; Zhou J; Zhang Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Sep; 34(9):850-5. PubMed ID: 19779255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of schizophrenia with "atypical antipsychotic drugs". Quality of life as a measure of treatment success].
    Krankenpfl J; 2002; 40(7-9):230-1. PubMed ID: 12514869
    [No Abstract]   [Full Text] [Related]  

  • 9. Maintenance therapy in schizophrenia: a critical comment.
    Chan SS; Ungvari GS
    Int J Neuropsychopharmacol; 2002 Sep; 5(3):277-81. PubMed ID: 12366880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipsychotic dose in maintenance treatment of schizophrenia: A retrospective study.
    Kumar V; Rao NP; Narasimha V; Sathyanarayanan G; Muralidharan K; Varambally S; Venkatasubramanian G; Gangadhar BN
    Psychiatry Res; 2016 Nov; 245():311-316. PubMed ID: 27567194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of novel antipsychotic drugs on quality of life among people suffering from schizophrenia.
    Jukić V; Barić V; Culav-Sumić J; Herceg M; Majdancić Z; Werft-Cop M
    Coll Antropol; 2003; 27 Suppl 1():119-24. PubMed ID: 12955901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maintenance Treatment With Antipsychotic Drugs in Schizophrenia: A Cochrane Systematic Review and Meta-analysis.
    Ceraso A; Lin JJ; Schneider-Thoma J; Siafis S; Heres S; Kissling W; Davis JM; Leucht S
    Schizophr Bull; 2022 Jun; 48(4):738-740. PubMed ID: 35556140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence-based treatment for first-episode schizophrenia?
    Carpenter WT
    Am J Psychiatry; 2001 Nov; 158(11):1771-3. PubMed ID: 11691680
    [No Abstract]   [Full Text] [Related]  

  • 14. Placebo controls in clinical trials: concerns about use in relapse prevention studies in schizophrenia.
    Emsley R; Fleischhacker WW; Galderisi S; Halpern LJ; McEvoy JP; Schooler NR
    BMJ; 2016 Sep; 354():i4728. PubMed ID: 27613560
    [No Abstract]   [Full Text] [Related]  

  • 15. Guidelines for depot antipsychotic treatment in schizophrenia. European Neuropsychopharmacology Consensus Conference in Siena, Italy.
    Kane JM; Aguglia E; Altamura AC; Ayuso Gutierrez JL; Brunello N; Fleischhacker WW; Gaebel W; Gerlach J; Guelfi JD; Kissling W; Lapierre YD; Lindström E; Mendlewicz J; Racagni G; Carulla LS; Schooler NR
    Eur Neuropsychopharmacol; 1998 Feb; 8(1):55-66. PubMed ID: 9452941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.
    Lewis SW; Davies L; Jones PB; Barnes TR; Murray RM; Kerwin R; Taylor D; Hayhurst KP; Markwick A; Lloyd H; Dunn G
    Health Technol Assess; 2006 May; 10(17):iii-iv, ix-xi, 1-165. PubMed ID: 16707074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis.
    Leucht S; Tardy M; Komossa K; Heres S; Kissling W; Salanti G; Davis JM
    Lancet; 2012 Jun; 379(9831):2063-71. PubMed ID: 22560607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is quality of life among minimally symptomatic patients with schizophrenia better following withdrawal or continuation of antipsychotic treatment?
    Beasley CM; Sutton VK; Taylor CC; Sethuraman G; Dossenbach M; Naber D
    J Clin Psychopharmacol; 2006 Feb; 26(1):40-4. PubMed ID: 16415704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful use of maintenance rTMS for 8 months in a patient with antipsychotic-refractory auditory hallucinations.
    Thirthalli J; Bharadwaj B; Kulkarni S; Gangadhar BN; Kharawala S; Andrade C
    Schizophr Res; 2008 Mar; 100(1-3):351-2. PubMed ID: 18252271
    [No Abstract]   [Full Text] [Related]  

  • 20. [How to improve compliance in the patients with schizophrenia?].
    Gourevitch R
    Encephale; 2006 Oct; 32(5 Pt 4):S929-30. PubMed ID: 17119511
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.